|
N (%)
|
256 (57.3)
|
191 (42.7)
|
0.022
|
|
Hypertension N (%)
|
25 (10)
|
49 (26)
|
< 0.001
|
|
Obstructive Sleep Apnea Syndrome, N (%)
|
42 (16)
|
66 (35)
|
< 0.001
|
|
Non-alcoholic fatty liver disease, N (%)
|
50 (19)
|
67 (35)
|
0.001
|
|
HOMA-IR
|
2.3 (2.2)
|
2.9 (2.2)
|
0.011
|
|
Insulin sensitivity index
|
5.4 (3.5)
|
3.6 (2.5)
|
0.005
|
|
Disposition index
|
6.9 (5.9)
|
2.6 (1.6)
|
< 0.001
|
|
Quantitative insulin sensitivity check index
|
0.36 (0.04)
|
0.34 (0.04)
|
0.005
|
|
Insulinogenic index
|
1.6 (1.7)
|
0.9 (0.7)
|
< 0.001
|
|
Total cholesterol, mmol l−1
|
4.9 (0.9)
|
5.2 (0.9)
|
0.022
|
|
LDL cholesterol, mmol l−1
|
2.9 (0.8)
|
3.2 (0.8)
|
0.033
|
|
HDL cholesterol, mmol l−1
|
1.5 (0.4)
|
1.3 (0.3)
|
0.016
|
|
Triglycerides, mmol l−1
|
1.1 (0.6)
|
1.4 (0.7)
|
< 0.001
|
|
Triglycerides/HDL cholesterol ratio
|
2 (1.6)
|
2.6 (1.9)
|
< 0.001
|
